Prognostic Impact of Residual Moderate Mitral Regurgitation Following Valve-in-Valve Transcatheter Aortic Valve Implantation.
Tomasz StankowskiSleiman Sebastian Aboul-HassanMohammed SalemKristin RochorSoeren SchenkTemirlan ErkenovFarzaneh Seifi ZinabAnja MuehleVolker HerwigAxel HarnathMichel Pompeu SáBasel RamlawiDirk FritzscheBartłomiej PerekPublished in: Brazilian journal of cardiovascular surgery (2023)
MR is common in patients with failed aortic bioprostheses, and improvement in MR-status was observed in over 40% of patients following VIV-TAVI. Residual moderate MR after VIV-TAVI is not associated with worse early outcomes, however, it was associated with increased mortality at five years of follow-up and worse NYHA class among survivors.
Keyphrases
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- ejection fraction
- transcatheter aortic valve replacement
- left ventricular
- contrast enhanced
- end stage renal disease
- magnetic resonance
- high intensity
- prognostic factors
- peritoneal dialysis
- mitral valve
- newly diagnosed
- cardiovascular events
- coronary artery disease
- young adults
- heart failure
- type diabetes
- risk factors
- magnetic resonance imaging
- skeletal muscle
- metabolic syndrome
- computed tomography
- atrial fibrillation